Literature DB >> 31511953

Normalization of organ bath contraction data for tissue specimen size: does one approach fit all?

Betul R Erdogan1, Irem Karaomerlioglu1, Zeynep E Yesilyurt1, Nihal Ozturk1, A Elif Muderrisoglu1, Martin C Michel2, Ebru Arioglu-Inan1.   

Abstract

Organ bath experiments are a key technology to assess contractility of smooth muscle. Despite efforts to standardize tissue specimen sizes, they vary to a certain degree. As it appears obvious that a larger piece of tissue should develop greater force, most investigators normalize contraction data for specimen size. However, they lack agreement which parameter should be used as denominator for normalization. A pre-planned analysis of data from a recent study was used to compare denominators used for normalization, i.e., weight, length, and cross-sectional area. To increase robustness, we compared force with denominator in correlation analysis and also coefficient of variation with different denominators. This was done concomitantly with urinary bladder strips and aortic rings and with multiple contractile stimuli. Our urinary bladder data show that normalization for strip weight yielded the tightest but still only moderate correlation (e.g., r2 = 0.3582 for peak carbachol responses based on 188 strips). In aorta, correlations were even weaker (e.g., r2 = 0.0511 for plateau phenylephrine responses normalized for weight based on 200 rings). Normalization for strip size is less effective in reducing data variability than previously assumed; the normalization denominator of choice must be identified separately for each preparation.

Entities:  

Keywords:  Aorta; Cross-sectional area; Length; Normalization; Urinary bladder; Weight

Mesh:

Substances:

Year:  2019        PMID: 31511953     DOI: 10.1007/s00210-019-01727-x

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  35 in total

1.  Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder.

Authors:  L A Stevens; D J Sellers; N G McKay; C R Chapple; R Chess-Williams
Journal:  Auton Autacoid Pharmacol       Date:  2006-07

2.  The essential role of phospho-T38 CPI-17 in the maintenance of physiological blood pressure using genetically modified mice.

Authors:  Qunhui Yang; Wataru Fujii; Noriyuki Kaji; Shigeru Kakuta; Kodai Kada; Masayoshi Kuwahara; Hirokazu Tsubone; Hiroshi Ozaki; Masatoshi Hori
Journal:  FASEB J       Date:  2018-01-05       Impact factor: 5.191

3.  Interaction of perivascular adipose tissue and sympathetic nerves in arteries from normotensive and hypertensive rats.

Authors:  J Török; A Zemančíková; Z Kocianová
Journal:  Physiol Res       Date:  2016-10-24       Impact factor: 1.881

4.  Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder.

Authors:  Tim Schneider; Peter Hein; Martina B Michel-Reher; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-30       Impact factor: 3.000

5.  A role for muscarinic receptors or rho-kinase in hypertension associated rat bladder dysfunction?

Authors:  Tim Schneider; Peter Hein; Jie Bai; Martin C Michel
Journal:  J Urol       Date:  2005-06       Impact factor: 7.450

6.  Length-tension relationship of urinary bladder strips from streptozotocin-diabetic rats.

Authors:  P A Longhurst; J Kang; A J Wein; R M Levin
Journal:  Pharmacology       Date:  1990       Impact factor: 2.547

7.  Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.

Authors:  S Meini; A Lecci; P Cucchi; R M Catalioto; M Criscuoli; C A Maggi
Journal:  J Pharmacol Exp Ther       Date:  1998-10       Impact factor: 4.030

8.  Bradykinin contracts rat urinary bladder largely independently of phospholipase C.

Authors:  Carsten Sand; Martin C Michel
Journal:  J Pharmacol Exp Ther       Date:  2013-10-21       Impact factor: 4.030

9.  Signal transduction underlying carbachol-induced contraction of rat urinary bladder. I. Phospholipases and Ca2+ sources.

Authors:  Tim Schneider; Peter Hein; Martin C Michel
Journal:  J Pharmacol Exp Ther       Date:  2003-10-07       Impact factor: 4.030

10.  Enhanced contractile responses of arteries from streptozotocin diabetic rats to sodium fluoride.

Authors:  L P Weber; W L Chow; W Abebe; K M MacLeod
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more
  8 in total

1.  Inhibition of Human Prostate and Bladder Smooth Muscle Contraction, Vasoconstriction of Porcine Renal and Coronary Arteries, and Growth-Related Functions of Prostate Stromal Cells by Presumed Small Molecule Gαq/11 Inhibitor, YM-254890.

Authors:  Alexander Tamalunas; Amin Wendt; Florian Springer; Anna Ciotkowska; Beata Rutz; Ruixiao Wang; Ru Huang; Yuhan Liu; Heiko Schulz; Stephan Ledderose; Giuseppe Magistro; Christian G Stief; Martin Hennenberg
Journal:  Front Physiol       Date:  2022-05-23       Impact factor: 4.755

2.  A Potential Role of Cholinergic Dysfunction on Impaired Colon Motility in Experimental Intestinal Chagas Disease.

Authors:  Mayra F Ricci; Samantha R Béla; Joana L Barbosa; Michele M Moraes; Ana L Mazzeti; Maria T Bahia; Laila S Horta; Helton da C Santiago; Jader S Cruz; Luciano Dos S A Capettini; Rosa M E Arantes
Journal:  J Neurogastroenterol Motil       Date:  2022-07-30       Impact factor: 4.725

Review 3.  In vitro contractile studies within isolated tissue baths: Translational research from Visible Heart® Laboratories.

Authors:  Weston J Upchurch; Paul A Iaizzo
Journal:  Exp Biol Med (Maywood)       Date:  2022-01-22

4.  Choice of y-axis can mislead readers.

Authors:  Betül R Erdogan; Jan Vollert; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-06-25       Impact factor: 3.000

5.  Picotamide inhibits a wide spectrum of agonist-induced smooth muscle contractions in porcine renal interlobar and coronary arteries.

Authors:  Bingsheng Li; Ru Huang; Ruixiao Wang; Yuhan Liu; Christian G Stief; Martin Hennenberg
Journal:  Pharmacol Res Perspect       Date:  2021-05

6.  Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729.

Authors:  Ru Huang; Bingsheng Li; Alexander Tamalunas; Raphaela Waidelich; Christian G Stief; Martin Hennenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-02-10       Impact factor: 3.000

7.  Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists.

Authors:  Annabel Spek; Bingsheng Li; Beata Rutz; Anna Ciotkowska; Ru Huang; Yuhan Liu; Ruixiao Wang; Frank Strittmatter; Raphaela Waidelich; Christian G Stief; Martin Hennenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-11       Impact factor: 3.000

8.  Concentration-dependent alpha1-Adrenoceptor Antagonism and Inhibition of Neurogenic Smooth Muscle Contraction by Mirabegron in the Human Prostate.

Authors:  Ru Huang; Yuhan Liu; Anna Ciotkowska; Alexander Tamalunas; Raphaela Waidelich; Frank Strittmatter; Christian G Stief; Martin Hennenberg
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.